Amanote Research
Register
Sign In
Structure-Based Discovery of Novel and Selective 5-Hydroxytryptamine 2B Receptor Antagonists for the Treatment of Irritable Bowel Syndrome
doi 10.1021/acs.jmedchem.5b01631.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Design and Synthesis of Piperazinylpyridine Derivatives as Novel 5-Ht1a Agonists/5-Ht3 Antagonists for the Treatment of Irritable Bowel Syndrome (IBS)
Chemical and Pharmaceutical Bulletin
Medicine
Drug Discovery
Chemistry
Efficacy and Safety of 5-Hydroxytryptamine 3 Receptor Antagonists in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Gastroenterology
Hepatology
Gastroenterology
Serotonin Receptor Modulators in the Treatment of Irritable Bowel Syndrome
Therapeutics and Clinical Risk Management
Postprandial Plasma 5-Hydroxytryptamine in Diarrhoea Predominant Irritable Bowel Syndrome: A Pilot Study
Gut
Gastroenterology
Discovery of Novel Triazole-Based Opioid Receptor Antagonists
Comparison of Various Treatment for Irritable Bowel Syndrome
BMJ
Evaluation of Drug Treatment in Irritable Bowel Syndrome
British Journal of Clinical Pharmacology
Pharmacology
The Irritable Bowel Syndrome.
Postgraduate Medical Journal
Medicine
Irritable Bowel Syndrome
JAMA - Journal of the American Medical Association
Medicine
